S-phase fraction as a predictor of prognosis in juvenile respiratory papillomatosis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 5, 1998, Pages 541-544

  Stern, Yoram ^a,b   Mueller, Kelly ^a   Paul Willging, J ^a   Myer III, Charles M ^a   Cotton, Robin T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ARTICLE; CELL CYCLE S PHASE; CHILD; DIPLOIDY; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; LARYNX PAPILLOMATOSIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SURGICAL TECHNIQUE;

EID: 0031900063     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.5.541     Document Type: Article

References (15)

1. Jones S, Myers G. Benign neoplasms of the larynx. Otolaryngol Clin North Am. 1985;17:157-178.
2. Quincey RE, Hall D, Crof CB. Laryngeal papillomatosis revisited: analysis of 113 patients. Clin Otol. 1989;74:217-225.
3. Nikolidis ET, Trost DC, Buchholz CL, Wilkinson EV. The relationship of histologic and clinical factors in laryngeal papillomatosis. Arch Pathol Lab Med. 1985; 109:24-29.
4. Lindeberg H. Laryngeal papillomas: histomorphometric evaluation of multiple and solitary lesions. Clin Otolaryngol. 1991;16:257-260.
5. Abramson AL, Sternberg BM, Winkler B. Laryngeal papillomatosis: clinical, histopathologic, and molecular studies. Laryngoscope. 1987;97:678-685.
6. Mounts P, Kashime H. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope. 1984;94:28-33.
7. Pou AM, Rimell FL, Jordan JA, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol. 1995;104:758-762.
8. Seckinger P, Sugarbaker E, Frankfurt D. DNA content in human cancer: application in pathology and clinical medicine. Arch Pathol Lab Med. 1989;113:619-626.
9. Vindelon LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry. 1990;11:763-770.
10. Demeter UV, Stoler MH, Broker TR, Chow LT. Induction of proliferating cell nuclear antigen in differentiated kerotinocytes of human papillomavirus-infected lesions. Hum Pathol. 1994;25:343-348.
11. Munger K, Werness BT, Pyson N, Harlow E, Homley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989;8:4099-4105.
12. Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV sequences distinct from those required for p53 binding and trans-activation. Cell. 1987;67:547-556.
13. Johnson TS, Williamson KD, Cramer MM, Peters LJ. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffinembedded sections: comparison with malignancy grading. Cytometry. 1985;6: 461-470.
14. Lykesfeldt AE, Balsvr IJ, Christensen IK, et al. DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease. Acta Oncol. 1988;27: 744-756.
15. Zaslav AL, Steinberg BM, Stamberg J, Lin YJ, Abramson AL. Chromosomal analysis of recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg. 1988; 114:1170-1174.